Member of Senior Leadership team for largest privately held pharmacy benefit manager. Strategic hire brought on to help take company to next level. Responsible for retail network strategy, pharmacy fraud, waste & abuse, drug rebating, sales prospect pricing, client analytics, and partnering with sales, account and operations teams to drive revenue growth – corporate top-line growth has exceeded 650% during tenure.Responsible for pharmacy network management and spread revenue optimization representing nearly 50% of company revenue across client and cash discount business. Developed client-focused strategies supported by enhanced reporting and analytics to increase revenues by more than 240% over five-year period.Redesigned contract and management model with major U.S. chain pharmacies to dramatically enhance relationships and deliver >$25M in incremental revenue annually. Led design of new clinical product pricing and marketing strategy converting revenue for clinical management services from zero to > $15MM.Launched business analytics team focused on opportunity identification, performance assessment, guarantee management and revenue optimization. Efforts have significantly enhanced business decision-making capabilities and generated >$250M in incremental revenue. Chaired Enterprise Strategy team responsible for budget allocation and project management of corporate strategic development portfolio.

Reported to Government Group President at largest pharmacy benefits management company and direct-mail prescription business in U.S. Company manages $33B+ of drug spending for 62MM consumers. Created and led finance function for new business unit with > $6B in revenues derived from client relationships in municipal, state and Federal government commercial markets, Medicaid and Medicare.

Built new business unit to deliver improvements in Merck-Medco consumer communications - achieve operating efficiencies, enhanced outcomes, and drive company toward a stronger consumer focus.Grew revenues from zero to $2.9MM through development of communications pricing strategy.Delivered $4MM in direct savings & cost avoidance through aggressive use of communications and campaign management techniques - reducing contact costs, improving operating efficiency and consumer & client satisfaction while reducing communications turnaround time by >25%.Delivered $2MM in savings pioneering use of automated in and outbound phone messaging. Saved > $1MM in consumer research and analytic costs while delivering key business findings.Leveraged research & analysis findings to achieve 10 trade press placements through aggressive PR activities and develop a unique external positioning story to drive competitive advantage. Received Individual Merit Award and supported retention of JD Powers #1 consumer rating.

Managed group of 40 responsible for rapid implementation of integrated information management strategy for division and aligning with emerging Internet deployment.Secured senior management approval for product development plan and repositioning strategy.Managed product revenues of >$10 million and co-led team focused on enhancing data sales strategy to pharmaceutical manufacturer partners.Significantly increased internal and client focus on value and opportunities of information services.

Led new group of 50 to drive business thinking within restructured marketing organization and deliver key services including market research, client reporting, risk management, business analysis, and product support for formulary, OTC and direct mail patient education program.Closed key market gaps by leading team to develop company's first restrictive formulary product and co-leading team responsible for delivering first Health Management reporting.Secured $1.2MM from OTC manufacturer for consumer communication & sampling program.

Managed staff of seven responsible for developing pharmacy benefit management services financial offers for new and renewing clients as well as new product pricing.Led group during period of margin expansion through substantial new client acquisition while maintaining relatively stable market pricing; established first pro-active risk management strategy.

Responsible for all communications with financial community and distribution of strategic intelligence.Presented IR strategic plan to CEO, implemented recommendations including first European IR program, first half-day business & research briefings to investment community by senior managers.Avoided "shocks" to share price by successfully managing expectations during time of declining earnings and healthcare reform and dramatically expanding access to senior management. Implemented communications strategy supporting merger with Medco; recognized with receipt of Chairman's Award and cited as a "coup" in Institutional Investor magazine.

Managed administrative aspects and performance of Company's pension plans. Recovered $1 million through analysis of convertible fund manager performance.